StimGuard Launches OAB "Protect" Randomized Controlled Neurostim Trial
https://www.massdevice.com/stimguard-launches-oab-neurostim-trial/
“Developing a minimally invasive implantable neuromodulation system at the tibial nerve has the potential to improve the symptoms of patients suffering from urinary urgency incontinence associated with overactive bladder without an expensive surgery. StimGuard’s technology has the potential to be that innovation,” study principal investigator Dr. Larry Sirls of the Oakland University William Beaumont School of Medicine said in a press release.
Prof of Anesthesiology, Interventional Pain Physician at IUMS
7 年Congrats
Accomplished Orthopedic Implant Executive Driving Exceptional Sales and Marketing Performance
8 年Congrats to the Stimwave team!
Realtor at Nest Seekers International
8 年Hope all is well for you Laura!